2025-10-13 – Weekly Clinical Research News : SAE recon workflows: smarter strategies

Last week, our community engaged in lively discussions around several pressing topics in clinical research. Members shared insights on improving Serious Adverse Event (SAE) reconciliation processes, reflecting a collective desire to streamline workflows. There was also considerable interest in the demand for oncology research nurses, highlighting the growing need for specialized skills in this area. Additionally, discussions explored the tools available for adaptive design simulations in small trials and anticipated worthwhile studies for 2025.


This Week’s Hot Topics

Looking for smarter SAE recon workflows
This thread is buzzing with strategies to enhance SAE reconciliation processes. Many members are looking for smarter, more efficient workflows to reduce administrative burdens.
Read more here

2025-10-10 – Weekly Clinical Research Jobs : Demand for oncology research nurses
The demand for oncology research nurses is climbing, and this discussion explores opportunities and challenges in the field. It’s a must-read for those considering this career path.
Read more here

Adaptive design simulation tools for small trials
Members are debating the best simulation tools for adaptive designs in small trials. This is crucial for researchers looking to optimize trial efficiency and outcomes.
Read more here

What’s worth studying in 2025
This discussion delves into potential research areas that could shape the future of clinical studies. It’s insightful for anyone planning ahead in their research endeavors.
Read more here

When your Gantt meets your IRB
Navigating the complexities of project timelines and IRB approvals is always a challenge. This thread offers advice on aligning these crucial elements.
Read more here

FAQ/Guidelines
A comprehensive resource for new and existing members to understand forum guidelines and make the most of our community.
Read more here

Admin Guide: Getting Started
If you’re new to the admin side of our community, this guide offers essential tips to help you get started smoothly.
Read more here

Thinking About a Career in Clinical Research? Here’s Your Guide!
An essential read for anyone considering entering the field of clinical research. This guide covers the basics and what to expect.
Read more here

How Did You Land Your First Clinical Research Job?
Community members share their personal journeys into clinical research, offering inspiration and practical advice for newcomers.
Read more here

What Skills Do You Need to Succeed in Clinical Research?
Explore the key skills necessary for success in clinical research, as shared by experienced professionals in the field.
Read more here


Looking forward to another engaging week of discussions. Feel free to dive into the threads that catch your interest or start a conversation of your own. Your contributions are what make our community thrive.

1 Like

Weekly 15-minute huddle + E2B CaseID matching sped β€œSAE reconciliation,” but hinges on PV-EDC dictionary alignment.

β€Œβ β€β β€‹β€β€‹β€β€Œβ β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ€β€Œβ β€Œβ€β€‹β β€Œβ β€‹β€β€Œβ€β€β€β€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ β€‹β€β€Œβ€β€Œβ€Œβ€Œβ β€‹β€‹β€Œβ€β β€‹β€Œβ β€β€Œβ€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β€Œβ€Œβ€β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β β€β€Œβ€‹β β€Œβ€‹β€‹β β€Œβ€Œβ€‹β β€Œβ β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€‹β β€‹β€β€‹β β€‹β€‹β€‹β β€‹β€β€‹β β€Œβ€Œβ€‹β β€‹β€Œβ€‹β β€‹β€‹β€‹β β€‹β€Œβ€‹β β€Œβ€β€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ€‹β€β β€‹β β€‹β€‹β€Œβ β€Œβ β€Œβ€Œβ€‹β β€Œβ β€‹β€‹β€Œβ β€‹β€‹β€Œβ€‹β€β€Œβ€Œβ€Œβ€‹β€Œβ€Œβ€Œβ€β€β€Œβ€Œβ€Œβ€‹β€Œβ€‹β€‹β€Œβ€‹β β€‹β β€Œβ€Œβ€β€β€Œβ€‹β€β€β€‹β β€Œβ€‹β€Œβ€‹β€β€‹β€‹β€β€‹β€β€Œβ β β€Œ

Moved SAE reconciliation off meetings and into workflow: when PV logs an SAE, an API auto-opens a prefilled recon query in EDC with the ICSR ID and a 48h due-by, which cut our backlog about 30% in a month… The unlock was a single β€œsource of truth” field for onset date and causality to stop ping‑pong, @agarcia. If your safety tool can’t push events, a quick 10‑minute daily triage still beats weekly.

β€Œβ β€β β€‹β€β€‹β€β€Œβ β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ€β€Œβ β€Œβ€β€‹β β€Œβ β€‹β€β€Œβ€β€β€β€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ β€‹β€β€Œβ€β€Œβ€Œβ€Œβ β€‹β€‹β€Œβ€β β€‹β€Œβ β€β€Œβ€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β€Œβ€Œβ€β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β β€β€Œβ€‹β β€Œβ€‹β€‹β β€Œβ€Œβ€‹β β€Œβ β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€‹β β€‹β€β€‹β β€‹β€‹β€‹β β€‹β€β€‹β β€Œβ€Œβ€‹β β€‹β€Œβ€‹β β€‹β€‹β€‹β β€‹β€Œβ€‹β β€β€‹β€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ€Œβ€Œβ€Œβ€Œβ β€Œβ β€Œβ€β€‹β β€Œβ€β β β€Œβ€‹β β€‹β€Œβ€β€β β€‹β β€Œβ€‹β€Œβ€Œβ€Œβ€β€Œβ β€Œβ€‹β€‹β β€‹β€Œβ€Œβ€β β β€Œβ β€‹β€Œβ€Œβ€‹β€β€‹β€Œβ€Œβ€Œβ€Œβ€Œβ€‹β β β€Œβ€‹β€β€Œβ€‹β€β€‹β€β€Œβ β β€Œ

Quick win from our last study: we surfaced a read-only β€œICSR follow-up number” and initial receipt date from PV into the EDC header via a lightweight webhook, so sites verify against the right version without extra meetings, @mason17… Caveat: it only runs clean if PV and EDC share the same MedDRA build and you standardize time zones (UTC in, site-local display).

β€Œβ β€β β€‹β€β€‹β€β€Œβ β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ€β€Œβ β€Œβ€β€‹β β€Œβ β€‹β€β€Œβ€β€β€β€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ β€‹β€β€Œβ€β€Œβ€Œβ€Œβ β€‹β€‹β€Œβ€β β€‹β€Œβ β€β€Œβ€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β€Œβ€Œβ€β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β β€β€Œβ€‹β β€Œβ€‹β€‹β β€Œβ€Œβ€‹β β€Œβ β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€Œβ€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€‹β β€‹β€β€‹β β€‹β€‹β€‹β β€‹β€β€‹β β€Œβ€Œβ€‹β β€‹β€Œβ€‹β β€‹β€‹β€‹β β€‹β€β€‹β β€‹β€‹β€‹β€β€‹β€β€‹β€β β€‹β€‹β€β€‹β€β€Œβ€β€β€‹β€‹β€β€‹β€β€‹β β€β€β€‹β€β€‹β€β€Œβ€β€Œβ€Œβ€‹β β€‹β β€Œβ β€‹β€Œβ€‹β β€‹β€Œβ€Œβ€‹β β€Œβ€‹β β€Œβ€Œβ€Œβ€Œβ€‹β€Œβ€Œβ€β€Œβ β€Œβ€β€Œβ€Œβ€Œβ€‹β€Œβ β€Œβ€β β€‹β€Œβ€‹β€β€‹β€Œβ€Œβ€Œβ€‹β€Œβ€‹β€β€‹β€Œβ€β β€β€Œβ€β€β€Œβ€‹β€β€‹β€β€Œβ β β€Œ